Skip to main content

Table 6 Risk factors for multi-drug bacteria (MDRB) colonization during hospital admissions

From: Multi-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients

Demographic parameters

No MDRB colonization no. (%)

MDRB colonization n (%)

P value

Agea

   

 ≤ 58

140 (58.6)

59 (48.4)

0.06

 > 58

99 (41.4)

63 (51.6)

 

Sex

   

 Male

130 (54.4)

85 (69.7)

0.005

 Female

109 (45.6)

37 (30.3)

 

Diagnosis

  

0.002

 AA

1 (0.4)

0 (0)

 

 Lymphoma

82 (34.3)

20 (16.4)

 

 ALL

21 (8.8)

8 (6.6)

 

 CLL/LPD

2 (0.8)

0 (0)

 

 AML

81 (33.9)

68 (55.7)

 

 CML

0

1 (0.8)

 

 MM

33 (13.8)

13 (10.7)

 

 MDS

9 (3.8)

5 (4.1)

 

 Other

10 (4.2)

7 (5.7)

 

Urinary catheter

  

0.64

 No

218 (91.2)

113 (92.6)

 

 Yes

21 (8.8)

9 (7.4)

 

Chemotherapy

  

0.15

 No

40 (16.7)

28 (23)

 

 Yes

199 (83.3)

94 (77)

 

Peripheral or central catheter

  

0.98

 No

2 (0.8)

1 (0.8)

 

 Yes

237 (99.2)

121 (99.2)

 

Previous antibiotic treatment

  

0.07

 No

164 (68.6)

72 (59)

 

 Yes

75 (31.4)

50 (41)

 

Allogeneic or autologous hematopoietic stem cell transplantation

  

0.02

 No

90 (37.7)

61 (50)

 

 Yes

149 (62.3)

61 (50)

 
  1. AA aplastic anemia, ALL acute lymphoblastic leukemia, CLL/LPD chronic lymphocytic leukemia/lymphoproliferative disorders, AML acute myeloid leukemia, CML chronic myeloid leukemia, MM multiple myeloma, MDS myelodysplastic syndrome
  2. aMedian age of patients at admission